by Team Small News | Jun 20, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for Pembrolizumab, a cancer drug used to treat various types of cancer, including melanoma, lung...
by Team Small News | Jun 17, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, has partnered with Dr. Reddy’s Laboratories, a leading pharmaceutical company, to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a monoclonal...
by Team Small News | Jun 16, 2025 | Dr Reddy's
In a significant breakthrough, the JR Puram police in Srikakulam have arrested a gang of eight individuals, including employees of top pharmaceutical firms, for stealing Semaglutide, a valuable anti-diabetic and weight-loss medicine, from Dr. Reddy’s...
by Team Small News | Jun 14, 2025 | Dr Reddy's
Alvotech, a global biotech company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar of Merck’s Keytruda (pembrolizumab) for the treatment of cancer. The partnership aims to bring a more...
by Team Small News | Jun 12, 2025 | Dr Reddy's
A significant theft has been uncovered at Dr. Reddy’s Laboratories, a pharmaceutical company, where eight individuals, including four employees, have been arrested for stealing Semaglutide, an anti-diabetic drug worth over ₹2 crore. The gang attempted to sell...
by Team Small News | Jun 10, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for the cancer drug Pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a...